GROOT
Footballguy
The 11.5 million shares are from April 27. This is old news. SCARE TACTIC. They are desperate.It was spiking and then they announced mote dilution. I'll be taking profits this morning.
Last edited by a moderator:
The 11.5 million shares are from April 27. This is old news. SCARE TACTIC. They are desperate.It was spiking and then they announced mote dilution. I'll be taking profits this morning.
I don't think so. The SEC filing from April 27:The 11.5 million shares are from April 27. This is old news. SCARE TACTIC. They are desperate.
Looks down to me right now. Seems like the party is over. You’ve got the touch man.AMC right back at it again in pre-market this a.m.
I keep waiting for a good spot to short this donk of a stonk ... But those danm apes ... Are their pockets bottomless?
Now I'm thinking, what the hell, I might as well join them. Where else am I going to make 20% in one day?
FWIW, I sold half of my AMC position and promptly went over to GME before the afternoon run up.I sold 1/3 of my position at 60. Over 8x gain. Still holding 500 shares at about $12.
Now...do I move these proceeds to buy a GME dip?
Very smart move even if it can go higher. You’ve made a great return and let’s be honest, AMC is not even close to worth its current market cap even if you assume they get back to their peak revenue/cash flow. At some point, AMC will continue to dilute and the market cap will reflect the actual fundamentals. So, unless retail investors want to lock their money up in a slow burn loss for years, people will jump ship after earnings reports keep coming in that show it’s not worth the price or when they are tired of dilution. It could happen really fast.It was spiking and then they announced mote dilution. I'll be taking profits this morning.
How? they can not create more shares without shareholder approvalVery smart move even if it can go higher. You’ve made a great return and let’s be honest, AMC is not even close to worth its current market cap even if you assume they get back to their peak revenue/cash flow. At some point, AMC will continue to dilute and the market cap will reflect the actual fundamentals. So, unless retail investors want to lock their money up in a slow burn loss for years, people will jump ship after earnings reports keep coming in that show it’s not worth the price or when they are tired of dilution. It could happen really fast.
“APES AGREE WITH MORE STONK! SOME STONK GOOD, MORE STONK BETTER! VOTE YES!”How? they can not create more shares without shareholder approval
I know it doesn’t seem like much, but a year ago, AMC had about 100 million shares. At this point, I think they are close to 500 million.11.5 M shares is 2.5% of the total shares of 450M - for AMC
I am holding for now - the timing is curious as it helps the fear mongering of the media but the reality is it does not change the fact that there are not enough shares at current prices for shorts to cover.
They literally just filed to sell more shares today and I believe they already passed a motion to dilute if necessary. They have also taken share count from just over 100 million to almost 500 million in a year. They’ve already diluted the #### out of the stock over the past year.How? they can not create more shares without shareholder approval
You aren't doing this right. We don't price stocks like that anymore.They literally just filed to sell more shares today and I believe they already passed a motion to dilute if necessary. They have also taken share count from just over 100 million to almost 500 million in a year. They’ve already diluted the #### out of the stock over the past year.
Are you actually arguing that AMC is really a $28B company? Pre pandemic they were worth $3-4B and their revenue has declined every year since around 2017. That was before Disney+, Apple+, HBO Max, Prime (buying MGM studio) and others were even around. Yes, movies will come back but outside of maybe a little pop, it’s not a growing business and AMC with all the added debt isn’t worth 10x their peak.
Who knows what is going on inside the head of some of these AMC investors, but they are making boatloads (on paper) so I can't fault them. I expect shares to trade in a narrow channel today, about $20-$120.They literally just filed to sell more shares today and I believe they already passed a motion to dilute if necessary. They have also taken share count from just over 100 million to almost 500 million in a year. They’ve already diluted the #### out of the stock over the past year.
Are you actually arguing that AMC is really a $28B company? Pre pandemic they were worth $3-4B and their revenue has declined every year since around 2017. That was before Disney+, Apple+, HBO Max, Prime (buying MGM studio) and others were even around. Yes, movies will come back but outside of maybe a little pop, it’s not a growing business and AMC with all the added debt isn’t worth 10x their peak.
AMC could have at least waited until the market was open to crap on everything.Tech on a roll. I'm thinking hard about trimming. Have to imagine the pending AMC crash will crush the market like the GME plummet did.
How? they can not create more shares without shareholder approval
I added another 7% to my HGEN total at $18.06. Keeping a little powder dry in case it drops more and resisting the urge to chase the falling Amazon knife. I think I'll add some more HGEN at $17 unless Amazon hits $3100 first.Tried to short one share of amc for the lolz and it said no shares were available.![]()
And I loaded the Hgen train again at 18.
Oh, nothing I am saying has anything to do with what the short term prices will be. There is truth to things are worth what people will it but there is also truth behind the actual company fundamentals and numbers. All overpriced tulips eventually crash, it’s just a matter of when because no one knows the peak until after it happened.Caveman33 said:Who knows what is going on inside the head of some of these AMC investors, but they are making boatloads (on paper) so I can't fault them. I expect shares to trade in a narrow channel today, about $20-$120.
I know you are joking but I do laugh at some articles about the new world of investing. Long term, fundamentals will always drive the price. While there may be some insanity both ways (shorts and short haters), that’s short term. Company profits, revenue, growth, products, revenue potential, outstanding share count, etc. drive the price. Free popcorn isn’t a fundamental! Diluting the #### out of shares is.BassNBrew said:You aren't doing this right. We don't price stocks like that anymore.
I divested myself from them months ago. Made some money but not as much as I could have when it was at its peak. I’m not a big fan of it anymore. A lot of other software related stocks I like better.For those who like to roll the dice, I'm eyeing the June 18 calls on AYX with $80 strike price. I think AYX rebounds from the mid-70s but whether it does it in the next few weeks or not, who knows. Those calls are trading for $1.30 which is pretty cheap for a company that was in the $100s not that long ago.
I tried to short 100 yesterday at $104 and it appeared to go through. An hour later it showed rejected.Tried to short one share of amc for the lolz and it said no shares were available.![]()
And I loaded the Hgen train again at 18.
Agreed - but if a bunch of Apes just won't sell and the stock is completely shorted.....................stbugs said:I know it doesn’t seem like much, but a year ago, AMC had about 100 million shares. At this point, I think they are close to 500 million.
This is not GME. There is no fear no fear mongering. AMC has diluted every original share from pre-pandemic by 80%. The market cap of AMC when it was at its peak was about 10% of what it is today. So, basically shares are worth 20% of what they were but the share price is still way up. Fundamentally, the stock is ridiculously overpriced. That’s not fear mongering, that’s actual fact.
I don’t like GME. I think they are priced as if they are already really successful (versus reality of declining revenue) and that’s not a given especially at the inflated market cap. That said, their market cap and dilution aren’t close to AMC. AMC is a company that very likely would have filed for bankruptcy if it wasn’t able to raise money at inflated prices. I don’t see AMC executives as being truly behind retail investors. The popcorn thing was a gimmick as seen by their dilution as soon as the price ran up like crazy.
This is important. The new DTCC rules say the clearinghouses need to report on their coverage on an on-going basis. This means people are watching and shenanigans are being reduced.Tried to short one share of amc for the lolz and it said no shares were available.![]()
And I loaded the Hgen train again at 18.
I have some of that stock. Please explain this to me like I am in first grade.For those looking to get in on a potential short squeeze ahead of time, checkout one of our old marijuana stocks $SNDL: https://twitter.com/CupAndrei/status/1397629413550927879
Retreated faster than a cowardly Private on the front lines.QS back up to $30
![]()
I hear they make pills for that now.Retreated faster than a cowardly Private on the front lines.
https://www.investopedia.com/articles/optioninvestor/08/synthetic-options.aspI have some of that stock. Please explain this to me like I am in first grade.For those looking to get in on a potential short squeeze ahead of time, checkout one of our old marijuana stocks $SNDL: https://twitter.com/CupAndrei/status/1397629413550927879
Here’s hoping for similar successPiggyback on all your HGEN hype with AMC proceeds. Also added 25 GME.
Bought some Jul CallsAnd I loaded the Hgen train again at 18.
Apparently this is what put it on my radar3 stocks to look into purchasing from Motley.
1. DermTech
Between 4 million and 4.5 million surgical skin biopsies are performed each year. Only around 180,000 cases of melanoma are found from these biopsies. That's a lot of cutting that ultimately proves unnecessary. Worse, these skin inspections sometimes fail to detect when melanoma or other skin cancer is present.
DermTech (NASDAQ: DMTK) addresses these problems. The company currently markets its Pigmented Lesion Assay (PLA) for diagnosing melanoma. There's no cutting required. Instead, an adhesive patch is placed on the skin, then removed and sent to a lab. Genomic testing is performed on the lesion to determine if the individual has melanoma.
This approach is 17 times less likely to miss a melanoma diagnosis. It's nearly 25% less expensive than surgical biopsy. Is there a big market for such a game-changing technology? You bet. DermTech estimates its total addressable market in skin cancer is close to $10 billion per year.
For now, the company is focused only on melanoma. However, its pipeline includes other products in development that could enable DermTech to target other types of skin cancer. The company's market cap currently stands at around $1 billion. DermTech should have a massive growth runway ahead of it.
I have some. I paired it with $OM as a derisked (FDA Approved) small cap biotech basket. I think now is probably a decent entry point to start.Anyone own DMTK? @stbugs?
I think it is a MF recommendation, but I do not know that. That's why I asked you specifically.
I'm interested and have been watching a bit since it ran. Trying to figure out if this is my entry point, bouncing off the $30 low or if there's another leg down to come.
I don't get worked up when insiders sell shares, but I'm always intrigued when they buy or receive shares, even restricted shares, without shedding some of what they have at current prices. Especially when it's someone with a CFO's background
I own a little, like a quarter share. Am I reading it correctly that the CFO acquired shares? I don't know the company inside and out, hence using their recs, but I do want to add. I've just been adding slower this year since some of the things I bought (aside from UPST) dipped with everything else. I probably should have known and honestly, I think I got one of the recent bottoms (5/13) right, but didn't take advantage. I am hoping for long term, don't really care that much short term, that maybe we have another dip starting today to really finish out some buys. I've created a list of some stocks that I'm thinking of selling to move money elsewhere. I feel like I have a little too much diversification.Anyone own DMTK? @stbugs?
I think it is a MF recommendation, but I do not know that. That's why I asked you specifically.
I'm interested and have been watching a bit since it ran. Trying to figure out if this is my entry point, bouncing off the $30 low or if there's another leg down to come.
I don't get worked up when insiders sell shares, but I'm always intrigued when they buy or receive shares, even restricted shares, without shedding some of what they have at current prices. Especially when it's someone with a CFO's background
NVDA is one of many stocks I looked at buying last March/April and wish I did, but it really seems extended at this point. Love the company, but a P/S of 20+ is a lot for a company with a $430B market cap. AMD for example is growing at a similar pace and has about half the revenue, but is worth 1/4 of NVDA. It kind of reminds me of TSLA where the price at $900 was just disconnected from the reality. NVDA just seems really rich at $700. I'm not planning to start a position now, should have back when it was much cheaper. Then again, almost everything has done awesome since March of last year.Threw a chunk into NVDA a couple days ago @ $647.
Up 5+ %
Planning to hold it at least through the split.
Now, maybe longer.